Boston launches two new defib families in Europe; offers US warranty on older models
This article was originally published in Clinica
Executive Summary
Boston Scientific has launched its Energen cardiac resynchronisation therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs) and Punctua CRT-Ds and ICDs in Europe and other non-US markets.